By Deena Beasley June 3 (Reuters) - Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more ...
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in the development of targeted ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
5don MSN
Colorectal cancer has a backup plan, and it begins when mature gut cells regain stem-like traits
In a recent study, Stevens researchers have shown how colorectal cancers can evolve from mature intestinal cells that revert ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...
The landmark success of a drug against an ‘undruggable’ cancer is spurring fresh optimism in the quest to treat seemingly ...
Morning Overview on MSN
A new AI can now predict how tens of thousands of genetic mutations push cells toward cancer — pointing drug makers straight at the ones that matter
Cancer researchers have spent decades cataloging mutations found in tumors, building databases that now hold millions of entries. The problem was never finding variants. It was figuring out which ones ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results